WallStreetZenWallStreetZen

NASDAQ: TSBX
Turnstone Biologics Corp Stock

$2.51+0.11 (+4.58%)
Updated Jul 11, 2024
TSBX Price
$2.51
Fair Value Price
-$1.08
Market Cap
$58.05M
52 Week Low
$1.63
52 Week High
$13.20
P/E
-0.27x
P/B
0.73x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$74.90M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.18
Operating Cash Flow
-$66M
Beta
3.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

TSBX Overview

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, and uveal melanoma, as well as an investigator sponsored trial to treat cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TSBX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TSBX ($2.51) is overvalued by 332.55% relative to our estimate of its Fair Value price of -$1.08 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TSBX ($2.51) is not significantly undervalued (332.55%) relative to our estimate of its Fair Value price of -$1.08 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TSBX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TSBX due diligence checks available for Premium users.

Be the first to know about important TSBX news, forecast changes, insider trades & much more!

TSBX News

Valuation

TSBX fair value

Fair Value of TSBX stock based on Discounted Cash Flow (DCF)
Price
$2.51
Fair Value
-$1.07
Undervalued by
334.06%
TSBX ($2.51) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TSBX ($2.51) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TSBX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TSBX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.27x
Industry
-14.46x
Market
31.84x

TSBX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.73x
Industry
6.37x
TSBX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TSBX's financial health

Profit margin

Revenue
$0.0
Net Income
-$19.6M
Profit Margin
0%
TSBX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$94.4M
Liabilities
$14.4M
Debt to equity
0.18
TSBX's short-term assets ($84.98M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TSBX's short-term assets ($84.98M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TSBX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$17.5M
Investing
$14.1M
Financing
$0.0
TSBX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

TSBX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
TSBX$58.05M+4.58%-0.27x0.73x
CLGN$58.42M0.00%-7.73x2.39x
BRNS$57.38M+2.44%-0.80x0.33x
ANEB$58.87M-2.16%-6.14x11.81x
RLYB$59.27M+8.33%-0.76x0.66x

Turnstone Biologics Stock FAQ

What is Turnstone Biologics's quote symbol?

(NASDAQ: TSBX) Turnstone Biologics trades on the NASDAQ under the ticker symbol TSBX. Turnstone Biologics stock quotes can also be displayed as NASDAQ: TSBX.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.

What is the 52 week high and low for Turnstone Biologics (NASDAQ: TSBX)?

(NASDAQ: TSBX) Turnstone Biologics's 52-week high was $13.20, and its 52-week low was $1.63. It is currently -80.98% from its 52-week high and 54.46% from its 52-week low.

How much is Turnstone Biologics's stock price per share?

(NASDAQ: TSBX) Turnstone Biologics stock price per share is $2.51 today (as of Jul 11, 2024).

What is Turnstone Biologics's Market Cap?

(NASDAQ: TSBX) Turnstone Biologics's market cap is $58.05M, as of Jul 12, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Turnstone Biologics's market cap is calculated by multiplying TSBX's current stock price of $2.51 by TSBX's total outstanding shares of 23,128,454.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.